Skip to main content
Clinical Trials/NCT04054947
NCT04054947
Completed
Not Applicable

Suicide Prevention in Rural Veterans During High-risk Care Transition Scenarios

White River Junction Veterans Affairs Medical Center1 site in 1 country60 target enrollmentOctober 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Suicidal and Self-injurious Behavior
Sponsor
White River Junction Veterans Affairs Medical Center
Enrollment
60
Locations
1
Primary Endpoint
The Beck Scale for Suicidal Ideation (BSS)
Status
Completed
Last Updated
last year

Overview

Brief Summary

In the United States (U.S.), suicide is a major public health concern. U.S. Veterans who live in rural areas may be at even higher risk for suicide than their urban counterparts. Available evidence indicates that suicide risk in rural U.S. Veterans is most concentrated during high-risk care transition scenarios such as discharge from an emergency room. There is limited knowledge about effective interventions to address suicide risk. There is a critical need to develop targeted interventions that address suicide risk during high-risk care transition periods. To be effective, these interventions should address key contributors to suicide risk such as reduced engagement in treatment. This clinical trial evaluates the effect of a suicide prevention intervention to support treatment engagement during high risk transition periods such as discharge from an emergency room.

Detailed Description

In the United States (U.S.), death by suicide is a notable public health concern and a particular problem in the U.S. Veteran population. Furthermore, U.S. Veterans who live in rural areas may be at even greater risk for suicide than their urban counterparts. These risks may be concentrated during times of transition in their treatment such as after emergency room discharge. Multiple interventions have been developed to target suicide risk during periods of transition but there is limited evidence regarding their efficacy in preventing suicide. Furthermore, a key contributor to suicide risk may include limited or no engagement in care. Therefore, developing interventions to support engagement in treatment may be effective ways to help mitigate suicide risk and promote participation in care. This clinical trial studies an intervention that is designed to help support treatment engagement during periods of high risk in Veterans who live in rural areas. The trial will recruit Veterans from various treatment settings such as the emergency room, residential drug treatment programs, primary care mental health clinics, and/or inpatient psychiatric units and follow them for a period of six months. The trial evaluates not only the effect of the intervention on suicidal behavior but also measures of engagement.

Registry
clinicaltrials.gov
Start Date
October 1, 2019
End Date
July 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brian Shiner

Staff Psychiatrist

White River Junction Veterans Affairs Medical Center

Eligibility Criteria

Inclusion Criteria

  • Inpatient psychiatric unit:
  • Per the unit psychiatrist, hospitalization was due to concerns about acute risk for self-harm including suicidal ideation, suicide attempt, and/or admitting provider deemed the patient was at imminent risk for self-harm
  • Be a Veteran eligible to receive VA services
  • Be able to speak English
  • Inpatient medical-surgical unit:
  • Received a mental health consultation during admission on the medical-surgical unit
  • Per the consult-liaison psychiatrist, patient was recently (within past three months of hospitalization) or is currently at risk for self-harm including suicidal ideation, suicide attempt, or self-harm
  • Be a Veteran eligible to receive VA services; be 18 years or older; be able to speak English
  • Residential Rehabilitation Center (RRC) program:
  • Per the RRC treatment team, patient was recently (within past three months of hospitalization) or is currently at risk for self-harm including suicidal ideation, suicide attempt, or self-harm

Exclusion Criteria

  • Unable to provide informed consent
  • Potentially vulnerable populations including prisoners, institutionalized patients, or involuntarily committed patients

Outcomes

Primary Outcomes

The Beck Scale for Suicidal Ideation (BSS)

Time Frame: Change from Baseline BSS at 1-, 3-, and 6-months

The BSS ranges from 0-38. While there is no established BSS cutoff score to classify suicide risk, there is evidence that higher scores on the BSS correspond to more severe suicidal ideation and that a change of five points or more on the total BSS scores may be clinically relevant. Mean scores at baseline were calculated.

Secondary Outcomes

  • Columbia Suicide Severity Rating Scale (C-SSRS)(Number of events according to the CSSR-S at 1-, 3-, and 6-months)
  • The Beck Scale for Hopelessness (BHS)(Change from Baseline BHS at 1-, 3-, and 6-months)
  • The Partners in Health Scale (PIH) (Self Management)(Change from Baseline PIH at 1-, 3-, and 6-months)
  • Multidimensional Scale of Perceived Social Support (MSPSS)(Change from Baseline MSPSS at 1-, 3-, and 6-months)
  • Interpersonal Needs Questionnaire 15: Perceived Burdensomeness (INQ-15 PB)(Change from Baseline INQ-15 PB at 1-, 3-, and 6-months)
  • The Interpersonal Needs Questionnaire-15: Thwarted Belongingness (INQ-15 TB)(Baseline, 1-month, 3-month, 6-month)
  • App Engagement Scale (AES) - for Mobile Applications(Change in AES scores at 1- and 6-months)
  • Suicide-Related Coping Scale (SRCS)(Change from Baseline SRCS at 1-, 3-, and 6-months)

Study Sites (1)

Loading locations...

Similar Trials